Home▸Intermittent Fasting & Metabolic Diets▸Fasting & Diabetes Medication Interaction Risk Simulator

⏱️ Fasting & Diabetes Medication Interaction Risk Simulator

A simulator for the risk of hypoglycemia when combining intermittent fasting with glucose-lowering medications (insulin, sulfonylureas), including dosage adjustment strategies to ensure safety.

Intermittent Fasting & Metabolic Diets2DModerate60 FPS
fasting-diabetes-medication-interaction-simulator ↗ Open standalone

Normal Medication Dosing Before Fasting

Standard insulin or sulfonylurea doses match regular meal timing.

  • 80–100: Typical fasting glucose (mg/dL healthy baseline)
  • 2–4h: Insulin peak action (post-injection onset)
  • 4–12h: Sulfonylurea half-life (varies by agent)
  • 3: Standard meals per day (doses timed to intake)

How mealtime dosing works

Doses are timed to expected carbohydrate intake.

Insulin vs sulfonylurea mechanism

Insulin replaces hormone; sulfonylureas force pancreatic release.

Why timing matters

Medication lowers glucose regardless of whether food arrives.

Fasting Window Begins While Medication Stays Active

No food intake starts, but prior medication keeps circulating.

  • 0–16h: Fasting duration options (intermittent fasting range)
  • Yes: Insulin still active (no food to offset it)
  • ~95: Glucose at fast start (mg/dL, near normal)
  • ~24h: Liver glycogen reserve (buffers early fasting)

No incoming glucose

Digestive glucose absorption stops entirely during the fast.

Medication doesn't pause

Insulin and sulfonylureas keep lowering glucose regardless.

Early buffering

Liver glycogen briefly offsets the falling blood sugar.

Unmatched Medication Drives Glucose Downward

Medication keeps working with no carbohydrates left to counter it.

  • Variable: Glucose decline rate (dose- and time-dependent)
  • Progressive: Glycogen depletion (buffer capacity shrinking)
  • ~70: Symptom onset threshold (mg/dL early warning)
  • Higher risk: Longer fasts (risk compounds with duration)

Depleting reserves

Glycogen stores shrink as fasting hours accumulate.

Dose-dependent risk

Higher doses accelerate the downward glucose slope.

Early warning signs

Shakiness and sweating can appear as glucose falls.

Blood Glucose Enters the Hypoglycemia Risk Zone

Glucose approaches levels that can trigger dangerous hypoglycemia.

  • <70: Hypoglycemia threshold (mg/dL clinical definition)
  • <54: Severe hypoglycemia (mg/dL requires urgent action)
  • Highest risk: High dose + long fast (combination effect)
  • 15–20g: Emergency glucose (fast-acting carbohydrate rule)

Why this combination is risky

High dose plus long fasting compounds the danger sharply.

Recognizing severe hypoglycemia

Confusion, sweating, and fainting signal a medical emergency.

Immediate response

Fast-acting glucose is needed before levels fall further.

Dose Adjustment Strategy Matched to Fasting Schedule

Reduced, fasting-aware dosing keeps glucose safely above danger levels.

  • 20–50%: Typical dose reduction (for extended fasting)
  • 70: Glucose stays above (mg/dL with proper adjustment)
  • Increased: Monitoring frequency (during fasting periods)
  • Required: Physician guidance (before changing any dose)

Reducing dose proactively

Doses are lowered before the fasting window begins.

Matching medication to eating pattern

Dose timing shifts to align with the last meal.

Working with a clinician

Any adjustment should be guided by a healthcare provider.

⚙ Under the hood

A simulator for the risk of hypoglycemia when combining intermittent fasting with glucose-lowering medications (insulin, sulfonylureas), including dosage adjustment strategies to ensure safety.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)